SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 636,822,022.65079832 with 590,150,211.79771733 in circulation. The last known price of Solana is 94.05303263 USD and is down -1.56 over the last 24 hours. It is currently trading on 1189 active market(s) with $1,556,044,818.54 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

Solana is being discussed amid a broad crypto pullback, with traders citing concerns about a reported major Binance security incident alongside persistent technical weakness. Bearish voices warn of more downside, while others view the dip as a buying opportunity and say they are accumulating or staking SOL.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders debating whether the agency will approve a narrower upper-limb label or issue another rejection. Recent hiring and FDA flexibility on rare-disease treatments are cited by bulls as encouraging signs, while skeptics say they do not resolve concerns about the efficacy data or guarantee approval.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,180,209.38070502. The last known price of Ethereum is 2,270.17304981 USD and is up 0.59 over the last 24 hours. It is currently trading on 14230 active market(s) with $5,193,092,001.43 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum discussion is dominated by the reported multibillion-dollar Binance hack and its potential impact on crypto-market confidence, with traders debating whether withdrawal and contagion concerns could prolong selling or whether claims that customer funds are covered will limit the fallout. Bearish calls on ETHs weakness compete with dip-buying and expectations of a rebound.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxons stronger-than-expected Q3 results, led by a surge in refining earnings, and its planned shareholder returns have drawn attention as the stock reached a 52-week high. Traders are debating whether the breakout can continue or the shares look extended after the run-up.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs upcoming earnings report is the dominant focus, with traders looking for guidance and growth to clear high expectations rather than relying on a beat alone. The pullback and broader weakness in AI and tech stocks have sharpened the debate: bulls expect strong results to support the premium valuation, while bears warn that even solid results could trigger a selloff if guidance disappoints.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs breakout to a 52-week high ahead of its Q3 report has fueled discussion of BRIUMVIs growth and upcoming subcutaneous data, alongside speculation about a buyout and a short squeeze. The buyout talk is unconfirmed, and some traders see the move as momentum around the earnings setup rather than evidence of a deal.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gileads stronger-than-expected quarterly results, raised product-sales outlook and continued HIV-franchise growth are driving attention as shares reach fresh highs. Traders are broadly positive on the results, while some interpret put-heavy options activity as possible profit-taking or a hedge after the run-up.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is drawing attention amid a steep selloff across AI and optical-infrastructure stocks, with traders debating whether the drop reflects broader sector and funding concerns or company-specific risks such as dilution and customer concentration. Bulls point to AI data-center demand and anticipate strong earnings, while bears remain cautious about the outlook and volatility.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPengs record October deliveries and rapid overseas growth are drawing attention, but traders are debating whether the higher volume will translate into better margins amid intense China EV competition. The upbeat delivery news is set against persistent concern over the stocks prolonged decline and broader weakness in Chinese equities.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA accelerated approval of a competing treatment for recurrent respiratory papillomatosis has put pressure on Precigens PAPZIMEOS and sparked debate over how much market share the rival could take. Traders point to Precigens first-mover position, full approval and established commercial launch, while others argue the new treatments different regimen could intensify competition.

statis crypto Watchlist

Bitcoin

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TopOptionsAlerts®

$SPY $TSLA $AAPL $PLTR Ladies &amp; Gents… this week is stacked:

Apple &amp; Palantir earnings Monday AH
JOLTS, ADP and NFP 
5 FED speakers 
Mid term Elections

More War or MOAT (Mother of All TACO) depending on mid term voting results… 

Let’s make some MONEY! 🤑🤑